{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:00:12Z","timestamp":1794330012328,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05582-6","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:21:25Z","timestamp":1754389285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Infrastructure and current practice of blood culture diagnostics in patients with sepsis: teachings and recommendations from the European Sepsis Care Survey"],"prefix":"10.1186","volume":"29","author":[{"given":"Christian S.","family":"Scheer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktay","family":"Demirkiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Steering Committee of the European Sepsis Alliance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"11","key":"5582_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"2","key":"5582_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri SS, Lai YL, Warner S, Strich JR, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21(2):241\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"5582_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/cid\/ciac727","volume":"76","author":"J Van Heuverswyn","year":"2023","unstructured":"Van Heuverswyn J, Valik JK, van der Werff DS, Hedberg P, Giske C, Naucler P. Association between time to appropriate antimicrobial treatment and 30-day mortality in patients with bloodstream infections: a retrospective cohort study. Clin Infect Dis. 2023;76(3):469\u201378.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5582_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00134-019-05871-z","volume":"46","author":"JJ De Waele","year":"2020","unstructured":"De Waele JJ, Schouten J, Beovic B, Tabah A, Leone M. Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts. Intensive Care Med. 2020;46(2):236\u201344.","journal-title":"Intensive Care Med"},{"issue":"2","key":"5582_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00134-020-05929-3","volume":"46","author":"N Arulkumaran","year":"2020","unstructured":"Arulkumaran N, Routledge M, Schlebusch S, Lipman J, Conway Morris A. Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med. 2020;46(2):225\u201335.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5582_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1164\/rccm.202406-1167OC","volume":"211","author":"CS Scheer","year":"2025","unstructured":"Scheer CS, Giamarellos-Bourboulis EJ, Ferrer R, et al. Status of sepsis care in European hospitals: results from an international cross-sectional survey. Am J Resp Crit Care Med. 2025;211(4):587\u201399.","journal-title":"Am J Resp Crit Care Med"},{"issue":"4","key":"5582_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.21037\/atm-20-5429","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Ma X, He H, et al. Compliance with the surviving sepsis campaign guideline 1-hour bundle for septic shock in China in 2018. Ann Transl Med. 2021;9(4):278.","journal-title":"Ann Transl Med"},{"issue":"11","key":"5582_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.cmi.2019.03.024","volume":"25","author":"EA Idelevich","year":"2019","unstructured":"Idelevich EA, Seifert H, Sundqvist M, et al. Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey. Clin Microbiol Infect. 2019;25(11):1399\u2013407.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"5582_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cmi.2024.05.014","volume":"30","author":"T Schoffelen","year":"2024","unstructured":"Schoffelen T, Papan C, Carrara E, et al. European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists). Clin Microbiol Infect. 2024;30(11):1384\u2013407.","journal-title":"Clin Microbiol Infect"},{"key":"5582_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf260","author":"T Koroki","year":"2025","unstructured":"Koroki T, Fujii M, Kotaki Y, et al. Contamination of blood cultures drawn from arterial catheters versus venipuncture or venous catheters in critically ill patients: a systematic review and meta-analysis. Clin Infect Dis. 2025. https:\/\/doi.org\/10.1093\/cid\/ciaf260.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5582_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13054-019-2431-8","volume":"23","author":"RS Nannan Panday","year":"2019","unstructured":"Nannan Panday RS, Lammers EMJ, Alam N, Nanayakkara PWB. An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the prehospital antibiotics against sepsis (PHANTASi) trial. Crit Care. 2019;23(1):182.","journal-title":"Crit Care"},{"issue":"1","key":"5582_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13054-021-03592-8","volume":"25","author":"Y Li","year":"2021","unstructured":"Li Y, Guo J, Yang H, Li H, Shen Y, Zhang D. Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2021;25(1):167.","journal-title":"Crit Care"},{"issue":"5","key":"5582_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/cid\/ciaa039","volume":"71","author":"V Fabre","year":"2020","unstructured":"Fabre V, Sharara SL, Salinas AB, Carroll KC, Desai S, Cosgrove SE. Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients. Clin Infect Dis. 2020;71(5):1339\u201347.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5582_CR14","doi-asserted-by":"publisher","first-page":"e0241921","DOI":"10.1128\/jcm.02429-21","volume":"60","author":"M Verway","year":"2022","unstructured":"Verway M, Brown KA, Marchand-Austin A, et al. Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study. J Clin Microbiol. 2022;60(4):e0241921.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"5582_CR15","doi-asserted-by":"publisher","first-page":"e2232576","DOI":"10.1001\/jamanetworkopen.2022.32576","volume":"5","author":"JT Thaden","year":"2022","unstructured":"Thaden JT, Cantrell S, Dagher M, et al. Association of follow-up blood cultures with mortality in patients with gram-negative bloodstream infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(9):e2232576.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"5582_CR16","first-page":"1776","volume":"65","author":"CN Canzoneri","year":"2017","unstructured":"Canzoneri CN, Akhavan BJ, Tosur Z, Andrade PEA, Aisenberg GM. Follow-up blood cultures in gram-negative bacteremia: are they needed? Clin. Infect Dis. 2017;65(11):1776\u20139.","journal-title":"Infect Dis"},{"issue":"1","key":"5582_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12879-022-07098-8","volume":"22","author":"YC Hsieh","year":"2022","unstructured":"Hsieh YC, Chen HL, Lin SY, Chen TC, Lu PL. Short time to positivity of blood culture predicts mortality and septic shock in bacteremic patients: a systematic review and meta-analysis. BMC Infect Dis. 2022;22(1):142.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5582_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/1469-0691.12608","volume":"20","author":"MS Hsu","year":"2014","unstructured":"Hsu MS, Huang YT, Hsu HS, Liao CH. Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014;20(9):892\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"5582_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cmi.2018.07.015","volume":"25","author":"S Simeon","year":"2019","unstructured":"Simeon S, Le Moing V, Tubiana S, et al. Time to blood culture positivity: an independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2019;25(4):481\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5582_CR20","doi-asserted-by":"publisher","first-page":"e212007","DOI":"10.1001\/jamanetworkopen.2021.2007","volume":"4","author":"SS Magill","year":"2021","unstructured":"Magill SS, O\u2019Leary E, Ray SM, et al. Assessment of the appropriateness of antimicrobial use in US hospitals. JAMA Netw Open. 2021;4(3):e212007.","journal-title":"JAMA Netw Open"},{"key":"5582_CR21","doi-asserted-by":"publisher","first-page":"576849","DOI":"10.3389\/fphar.2020.576849","volume":"11","author":"JVM Pedroso","year":"2020","unstructured":"Pedroso JVM, Motter FR, Koba ST, et al. Feasibility of de-escalation implementation for positive blood cultures in patients with sepsis: a prospective cohort study. Front Pharmacol. 2020;11:576849.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5582_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.18433\/jpps29737","volume":"21","author":"T Niimura","year":"2018","unstructured":"Niimura T, Zamami Y, Imai T, et al. Evaluation of the benefits of de-escalation for patients with sepsis in the emergency intensive care unit. J Pharm Pharm Sci. 2018;21(1):54\u20139.","journal-title":"J Pharm Pharm Sci"},{"key":"5582_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1471-2334-14-272","volume":"14","author":"M Koupetori","year":"2014","unstructured":"Koupetori M, Retsas T, Antonakos N, et al. Bloodstream infections and sepsis in greece: over-time change of epidemiology and impact of de-escalation on final outcome. BMC Infect Dis. 2014;14:272.","journal-title":"BMC Infect Dis"},{"issue":"13","key":"5582_CR24","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2014.2637","volume":"311","author":"KM Kaukonen","year":"2014","unstructured":"Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and new zealand, 2000\u20132012. JAMA. 2014;311(13):1308\u201316.","journal-title":"JAMA"},{"issue":"6","key":"5582_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00134-024-07369-9","volume":"50","author":"YM Arabi","year":"2024","unstructured":"Arabi YM, Belley-Cote E, Carsetti A, et al. European society of intensive care medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids. Intensive Care Med. 2024;50(6):813\u201331.","journal-title":"Intensive Care Med"},{"issue":"3","key":"5582_CR26","first-page":"101078","volume":"41","author":"L Muller","year":"2022","unstructured":"Muller L, Joannes-Boyau O. Isotonic saline, balanced fluids, and chloride toxicity in ICU: lessons from the PLUS trial. Anaesth Crit Care Pain Med. 2022;41(3):101078.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"6","key":"5582_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/SHK.0000000000002193","volume":"60","author":"L Jia","year":"2023","unstructured":"Jia L, Wang P, Li C, Xie J. The efficacy and safety of vasopressors for septic shock patients: a systemic review and network meta-analysis. Shock. 2023;60(6):746\u201352.","journal-title":"Shock"},{"key":"5582_CR28","unstructured":"Adamis G, Akinosoglou K, Anisoglou S et al. Hellenic sepsis study group booklet on sepsis definitions-diagnostic approach- treatment recommendations. 2023 https:\/\/sepsis.gr\/wp-content\/uploads\/2024\/05\/HISS_Booklet_on_Sepsis_2023.pdf"},{"issue":"1","key":"5582_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12879-022-07653-3","volume":"22","author":"E Sieswerda","year":"2022","unstructured":"Sieswerda E, Bax HI, Hoogerwerf JJ, et al. The 2021 Dutch working party on antibiotic policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults. BMC Infect Dis. 2022;22(1):687.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"5582_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, et al. European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care Medicine). Clin Microbiol Infect. 2022;28(4):521\u201347.","journal-title":"Clin Microbiol Infect"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05582-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:35:22Z","timestamp":1757356522000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5582"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05582-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable since this a position manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Christian S. Scheer discloses funding from European Sepsis Alliance for conducting the European Sepsis Care Survey and funding from Becton and Dickinson for technical realisation of the project. Antonio Artigas discloses a BIOVAP-2 PSP study grant from Abionic; a Septibell study grant from Loop-Dx; Consulting fees from Grifols for Evaluation Albus awards, Fabentech for Scientific advisor of EPIC-CROWN-2 project, Lilly Foundation for Scientific Advisor committee, Aerogen for Spanish Advisory meeting; Board participation ImmuneSep (DSMB Committee), Apeptico (DSMB Committee), Exvastat (Scientific Advisor Board). Konrad Reinhart discloses holding shares from InflaRx NV, which is based in Jena, Germany and listed at NASDQ. He is the Founding President of the Global Sepsis Alliance. Adam Linder has nothing to disclose. E. J. Giamarellos-Bourboulis has received honoraria from Abbott Products Operations AG, bioM\u00e9rieux Inc, Sobi, and ThermoFisher Brahms GmbH; independent educational grants from Abbott Products Operations, bio M\u00e9rieux Inc, Gentian, InCyte, MSD, Novartis, UCB, PHC Europe BV, Swedish Orphan Biovitrum AB (publ) (Sobi); and funding from the Horizon 2020 European Grants ImmunoSep and RISCinCOVID and the Horizon Health grant EPIC-CROWN-2, Homi-LUNG and POINT (granted to the Hellenic Institute for the Study of Sepsis or to the National and Kapodistrian University of Athens). The other authors do not report any conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}